Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenograftsGaspar J. Kitange, Jann N. Sarkaria, Brett L. Carlson et al.|Neuro-Oncology|2008Cited by 387
Drivers, trends, and potential impacts of long-term coastal reclamation in China from 1985 to 2010Bo Tian, Yunxuan Zhou, Wenting Wu et al.|Estuarine Coastal and Shelf Science|2016Cited by 333
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177Paul D. Brown, Jan C. Buckner, Sunil Krishnan et al.|Journal of Clinical Oncology|2008Cited by 275
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panelJann N. Sarkaria, C. David James, Lin Yang et al.|Molecular Cancer Therapeutics|2007Cited by 203
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cellsLing Cen, Jann N. Sarkaria, Brett L. Carlson et al.|Neuro-Oncology|2012Cited by 187